Trex Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.trex.bio
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients
Phase 1
Recruiting
- Conditions
- Moderate-to-severe Atopic Dermatitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- TRex Bio, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT06934252
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
News
No news found